Erratum: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: Report from the Italian Multiple Sclerosis Study group (Neurological Sciences (2014))

Antonio Bertolotto, Marco Capobianco, Maria Pia Amato, Elisabetta Capello, Ruggero Capra, Diego Centonze, Maria Di Ioia, Antonio Gallo, Luigi Grimaldi, Luisa Imberti, Alessandra Lugaresi, Chiara Mancinelli, Maria Giovanna Marrosu, Lucia Moiola, Enrico Montanari, Silvia Romano, Luigina Musu, Damiano Paolicelli, Francesco Patti, Carlo PozzilliSilvia Rossi, Marco Salvetti, Gioachino Tedeschi, Maria Rosaria Tola, Maria Trojano, Mauro Zaffaroni, Simona Malucchi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1645-1646
Number of pages2
JournalNeurological Sciences
Volume35
Issue number10
DOIs
Publication statusPublished - Oct 1 2014

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology

Cite this